Short Bowel Syndrome Clinical Trial
Official title:
MR Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
It is essential to know intestinal length and anastomotic type in post-operative short bowel
syndrome patients. These parameters can help predict long-term intestinal failure with
long-term parenteral nutrition usually needed for smallest lengths. Sometimes these
parameters are unfortunately missing for lack of intraoperative measurement. Thus, it is
necessary to develop non-invasive and reproducible techniques to assess small bowel length.
This is the reason why the investigators will evaluate magnetic resonance (MR)-enterography
and barium follow-through in this indication. There are at this time only two small studies
evaluating barium follow-through for intestinal length measurement, and none evaluating
MR-enterography. However, a major advantage of the latter is the lack of radiation exposure
and possibility to perform 3D.
This will be an open labelled single center crossover study. Short bowel syndrome patients
of the investigators center will be included after consent. The sequence of exams (MR
enterography followed by barium follow-through or vice-versa) will be randomly assigned.
Peroperative short bowel length measurement will be available for all patients. There will
be one month between the two exams.
The main objective of this study is to assess the performance of MR-enterography in short
bowel measurement in short bowel syndrome patients, the gold standard being peroperative
length. Secondary objectives are to assess the performance of barium follow-through in short
bowel measurement in these patients, and to show that barium follow-through does not perform
better than MR-enterography. For that purpose the investigators will include 50 patients
over 2 years.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | July 2012 |
Est. primary completion date | October 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Intraoperative small bowel length < 200 cm - Males and females between 18 and 85 years of age - Patient with social insurance - Signature of informed consent Exclusion Criteria: - Allergy to contrast product - Enterostomy closure expected within 2 months after randomization - Pregnancy or breast feeding woman - Swallowing disorders - Deprivation of liberty - Contraindications to magnetic resonance imaging (pace-maker, metal implant, known allergy to gadolinium) |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | Service d'Hépato-Gastroentérologie et Nutrition Clinique - CHU Nice - hôpital Archet 2 | Nice |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the lack of difference between surgical and MR enterography small bowel length measurement with a comparison sample test | at 3 months | No | |
Secondary | Assessment of the lack of difference between surgical and barium follow through small bowel length measurement with a comparison sample test | at 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05635747 -
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
|
||
Completed |
NCT01891279 -
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
|
N/A | |
Completed |
NCT00930644 -
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
|
Phase 3 | |
Completed |
NCT01696656 -
Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency
|
N/A | |
Completed |
NCT00910104 -
Cholestasis Reversal: Efficacy of IV Fish Oil
|
Phase 2/Phase 3 | |
Completed |
NCT04981262 -
Improved Quality of Life in Children With Intestinal Failure
|
N/A | |
Completed |
NCT01930539 -
Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp
|
N/A | |
Recruiting |
NCT05023382 -
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
|
||
Recruiting |
NCT04733066 -
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
|
||
Terminated |
NCT00742157 -
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
|
Phase 4 | |
Completed |
NCT04743960 -
Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
|
N/A | |
Completed |
NCT03690206 -
Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)
|
Phase 3 | |
Terminated |
NCT02266849 -
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
|
Phase 3 | |
Completed |
NCT01306838 -
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
|
Early Phase 1 | |
Completed |
NCT01380366 -
rHGH and Intestinal Permeability in Intestinal Failure
|
Phase 4 | |
Completed |
NCT00248573 -
Mechanisms of Adaptation in Human Short Bowel Syndrome
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03371862 -
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
|
Phase 2 | |
Completed |
NCT04474743 -
Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study
|
||
Completed |
NCT00067860 -
Diet/Growth Factor Mechanisms of Gut Adaptation
|
Phase 2 | |
Terminated |
NCT04046328 -
Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
|
Phase 2 |